In addition, EZH2 exerts a negative influence on the expression of pro-apoptotic factors such as Puma and Bad, as well as cell cycle inhibitors like p21, ultimately promoting the development of SCLC tumors (66). This evidence concerns the gene EZH2 and small cell lung carcinoma.